593 results on '"Henry A. Pitt"'
Search Results
502. Reexploration for periampullary carcinoma: Resectability, perioperative results, pathology and long-term outcome
- Author
-
Charles J. Yeo, John L. Cameron, Henry A. Pitt, John J. Huang, Keith D. Lillemoe, Taylor A. Sohn, and Ralph H. Hruban
- Subjects
Male ,Reoperation ,Ampulla of Vater ,medicine.medical_specialty ,Pathology ,Time Factors ,Exploratory laparotomy ,medicine.medical_treatment ,Common Bile Duct Neoplasms ,Adenocarcinoma ,Pancreaticoduodenectomy ,Laparotomy ,medicine ,Humans ,Survival rate ,Aged ,Retrospective Studies ,Hepatology ,business.industry ,Mortality rate ,Gastroenterology ,Perioperative ,Surgery ,Pancreatic Neoplasms ,Survival Rate ,Treatment Outcome ,Pancreatectomy ,Female ,business ,Complication ,Research Article ,Exploratory surgery - Abstract
OBJECTIVE: This single-institution experience retrospectively reviews the outcomes of patients undergoing reexploration for periampullary carcinoma at a high-volume center. SUMMARY BACKGROUND DATA: Many patients are referred to tertiary centers with periampullary carcinoma after their tumors were deemed unresectable at previous laparotomy. In carefully selected patients, tumor resection is often possible; however, the perioperative results and long-term outcome have not been well defined. METHODS: From November 1991 through December 1997, 78 patients who underwent previous exploratory laparotomy and/or palliative surgery for suspected periampullary carcinoma underwent reexploration. The operative outcome, resectability rate, pathology, and long-term survival rate were compared with 690 concurrent patients who had not undergone previous exploratory surgery. RESULTS: Fifty-two of the 78 patients (67%) undergoing reexploration underwent successful resection by pancreaticoduodenectomy; the remaining 26 patients (34%) were deemed to have unresectable disease. Compared with the 690 patients who had not undergone recent related surgery, the patients in the reoperative group were similar with respect to gender, race, and resectability rate but were significantly younger. The distribution of periampullary cancers by site in the reoperative group undergoing pancreaticoduodenectomy (n = 52) was 60%, 19%, 15%, and 6% for pancreatic, ampullary, distal bile duct, and duodenal tumors, respectively. These figures were similar to the 65%, 14%, 16% and 5% for resectable periampullary cancers found in the primary surgery group (n = 460). Intraoperative blood loss and transfusion requirements did not differ between the two groups. However, the mean operative time was 7.4 hours in the reoperative group, significantly longer than in the control group. On pathologic examination, reoperative patients had smaller tumors, and the percentage of patients with positive lymph nodes in the resection specimen was significantly less. The incidence of positive margins was similar between the two groups. Postoperative lengths of stay, complication rates, and perioperative mortality rates were not higher in reoperative patients. The long-term survival rate was similar between the two resected groups, with a median survival of 24 months in the reoperative group and 20 months in those without previous exploration. CONCLUSIONS: These data demonstrate that patients undergoing reoperation for periampullary carcinoma have similar resectability, perioperative morbidity and mortality, and long-term survival rates as patients undergoing initial exploration. The results suggest that selected patients considered to have unresectable disease at previous surgery should undergo restaging and reexploration at specialized high-volume centers.
- Published
- 1998
- Full Text
- View/download PDF
503. Preface
- Author
-
Henry A. Pitt
- Subjects
Oncology ,Surgery - Published
- 1998
- Full Text
- View/download PDF
504. 2040 Continuous infusion (Cl) 5-FU and leucovorin (LCV) combined with hepatic (H), nodal (N), and tumor bed (TB) irradiation (XRT) following panceaticoduodenectomy (PDD) for head of pancreas (HOP) and other periampullary (PA) adenocarcinoma
- Author
-
John L. Cameron, Sarah E. Ord, M.L. Zahurek, Keith D. Lillemoe, Thomas L. Haulk, Ralph H. Hruban, T. A. Sohn, Louise B. Grochow, Ross A. Abrams, Charles J. Yeo, Anuradha Chakravarthy, and Henry A. Pitt
- Subjects
Cancer Research ,medicine.medical_specialty ,Radiation ,business.industry ,Continuous infusion ,Head of pancreas ,medicine.disease ,Hop (networking) ,Surgery ,medicine.anatomical_structure ,Oncology ,Medicine ,Adenocarcinoma ,Radiology, Nuclear Medicine and imaging ,Tumor bed ,business ,Nuclear medicine ,NODAL - Published
- 1996
- Full Text
- View/download PDF
505. p53 and K-RAS gene mutations in cholangiocarcinoma
- Author
-
Rh Hruban, Attila Nakeeb, Henry A. Pitt, Rjc Slebos, G. J. A. Offerhaus, and WC Dooley
- Subjects
Hepatology ,Cancer research ,Gene mutation ,Biology - Published
- 1995
- Full Text
- View/download PDF
506. Methods and timing of biliary drainage for acute cholangitis: Tokyo Guidelines.
- Author
-
Masato Nagino, Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Yuichi Yamashita, Toshio Tsuyuguchi, Keita Wada, Toshihiko Mayumi, Masahiro Yoshida, Fumihiko Miura, Steven M. Strasberg, Henry A. Pitt, Jacques Belghiti, Sheung-Tat Fan, Kui-Hin Liau, Giulio Belli, Xiao-Ping Chen, Edward Cheuck-Seen Lai, Benny P. Philippi, and Harjit Singh
- Abstract
Abstract??Biliary drainage is a radical method to relieve cholestasis, a cause of acute cholangitis, and takes a central part in the treatment of acute cholangitis. Emergent drainage is essential for severe cases, whereas patients with moderate and mild disease should also receive drainage as soon as possible if they do not respond to conservative treatment, and their condition has not improved. Biliary drainage can be achieved via three different routes/procedures: endoscopic, percutaneous transhepatic, and open methods. The clinical value of both endoscopic and percutaneous transhepatic drainage is well known. Endoscopic drainage is associated with a low morbidity rate and shorter duration of hospitalization; therefore, this approach is advocated whenever it is applicable. In endoscopic drainage,eitherendoscopic nasobiliary drainage (ENBD) or tube stent placement can be used. There is no significant difference in the success rate, effectiveness, and morbidity between the two procedures. The decision to perform endoscopic sphincterotomy (EST) is made based on the patient's condition and the number and diameter of common bile duct stones. Open drainage, on the other hand, should be applied only in patients for whom endoscopic or percutaneous transhepatic drainage is contraindicated or has not been successfully performed. Cholecystectomy is recommended in patients with gallbladder stones, following the resolution of acute cholangitis with medical treatment, unless the patient has poor operative risk factors or declines surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
507. Need for criteria for the diagnosis and severity assessment of acute cholangitis and cholecystitis: Tokyo Guidelines.
- Author
-
Miho Sekimoto, Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Masahiro Yoshida, Toshihiko Mayumi, Fumihiko Miura, Keita Wada, Masahiko Hirota, Yuichi Yamashita, Steven Strasberg, Henry A. Pitt, Jacques Belghiti, Eduardo de Santibanes, Thomas R. Gadacz, Serafin C. Hilvano, Sun-Whe Kim, Kui-Hin Liau, Sheung-Tat Fan, and Giulio Belli
- Abstract
Abstract??The Tokyo Guidelines formulate clinical guidance for healthcare providers regarding the diagnosis, severity assessment, and treatment of acute cholangitis and acute cholecystitis. The Guidelines were developed through a comprehensive literature search and selection of evidence. Recommendations were based on the strength and quality of evidence. Expert consensus opinion was used to enhance or formulate important areas where data were insufficient. A working group, composed of gastroenterologists and surgeons with expertise in biliary tract surgery, supplemented with physicians in critical care medicine, epidemiology, and laboratory medicine, was selected to formulate draft guidelines. Several other groups (including members of the Japanese Society for Abdominal Emergency Medicine, the Japan Biliary Association, and the Japanese Society of Hepato-Biliary-Pancreatic Surgery) have reviewed and revised the draft guidelines. To build a global consensus on the management of acute biliary infection, an international expert panel, representing experts in this area, was established. Between April 1 and 2, 2006, an International Consensus Meeting on acute biliary infections was held in Tokyo. A consensus was determined based on best available scientific evidence and discussion by the panel of experts. This report describes the highlights of the Tokyo International Consensus Meeting in 2006. Some important areas focused on at the meeting include proposals for internationally accepted diagnostic criteria and severity assessment for both clinical and research purposes. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
508. Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.
- Author
-
Atsushi Tanaka, Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Masahiro Yoshida, Fumihiko Miura, Masahiko Hirota, Keita Wada, Toshihiko Mayumi, Harumi Gomi, Joseph S. Solomkin, Steven M. Strasberg, Henry A. Pitt, Jacques Belghiti, Eduardo de Santibanes, Robert Padbury, Miin-Fu Chen, Giulio Belli, Chen-Guo Ker, and Serafin C. Hilvano
- Abstract
Abstract??Antimicrobial agents should be administered to all patients with suspected acute cholangitis as a priority as soon as possible. Bile cultures should be performed at the earliest opportunity. The important factors which should be considered in selecting antimicrobial therapy include the agent's activity against potentially infecting bacteria, the severity of the cholangitis, the presence or absence of renal and hepatic diseases, the patient's recent history of antimicrobial therapy, and any recent culture results, if available. Biliary penetration of the microbial agents should also be considered in the selection of antimicrobials, but activity against the infecting isolates is of greatest importance. If the causative organisms are identified, empirically chosen antimicrobial drugs should be replaced by narrower-spectrum antimicrobial agents, the most appropriate for the species and the site of the infection. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
509. Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines.
- Author
-
Fumihiko Miura, Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Keita Wada, Masahiko Hirota, Masato Nagino, Toshio Tsuyuguchi, Toshihiko Mayumi, Masahiro Yoshida, Steven M. Strasberg, Henry A. Pitt, Jacques Belghiti, Eduardo de Santibanes, Thomas R. Gadacz, Dirk J. Gouma, Sheung-Tat Fan, Miin-Fu Chen, Robert T. Padbury, and Philippus C. Bornman
- Abstract
Abstract??Diagnostic and therapeutic strategies for acute biliary inflammation/infection (acute cholangitis and acute cholecystitis), according to severity grade, have not yet been established in the world. Therefore we formulated flowcharts for the management of acute biliary inflammation/infection in accordance with severity grade. For mild (grade I) acute cholangitis, medical treatment may be sufficient/appropriate. For moderate (grade II) acute cholangitis, early biliary drainage should be performed. For severe (grade III) acute cholangitis, appropriate organ support such as ventilatory/circulatory management is required. After hemodynamic stabilization is achieved, urgent endoscopic or percutaneous transhepatic biliary drainage should be performed. For patients with acute cholangitis of any grade of severity, treatment for the underlying etiology, including endoscopic, percutaneous, or surgical treatment should be performed after the patient's general condition has improved. For patients with mild (grade I) cholecystitis, early laparoscopic cholecystectomy is the preferred treatment. For patients with moderate (grade II) acute cholecystitis, early laparoscopic or open cholecystectomy is preferred. In patients with extensive local inflammation, elective cholecystectomy is recommended after initial management with percutaneous gallbladder drainage and/or cholecystostomy. For the patient with severe (grade III) acute cholecystitis, multiorgan support is a critical part of management. Biliary peritonitis due to perforation of the gallbladder is an indication for urgent cholecystectomy and/or drainage. Delayed elective cholecystectomy may be performed after initial treatment with gallbladder drainage and improvement of the patient's general medical condition. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
510. Surgical treatment of patients with acute cholecystitis: Tokyo Guidelines.
- Author
-
Yuichi Yamashita, Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Masahiko Hirota, Fumihiko Miura, Toshihiko Mayumi, Masahiro Yoshida, Steven Strasberg, Henry A. Pitt, Eduardo de Santibanes, Jacques Belghiti, Markus W. Büchler, Dirk J. Gouma, Sheung-Tat Fan, Serafin C. Hilvano, Joseph W.Y. Lau, Sun-Whe Kim, Giulio Belli, and John A. Windsor
- Abstract
Abstract??Cholecystectomy has been widely performed in the treatment of acute cholecystitis, and laparoscopic cholecystectomy has been increasingly adopted as the method of surgery over the past 15 years. Despite the success of laparoscopic cholecystectomy as an elective treatment for symptomatic gallstones, acute cholecystitis was initially considered a contraindication for laparoscopic cholecystectomy. The reasons for it being considered a contraindication were the technical difficulty of performing it in acute cholecystitis and the development of complications, including bile duct injury, bowel injury, and hepatic injury. However, laparoscopic cholecystectomy is now accepted as being safe for acute cholecystitis, when surgeons who are expert at the laparoscopic technique perform it. Laparoscopic cholecystectomy has been found to be superior to open cholecystectomy as a treatment for acute cholecystitis because of a lower incidence of complications, shorter length of postoperative hospital stay, quicker recuperation, and earlier return to work. However, laparoscopic cholecystectomy for acute cholecystitis has not become routine, because the timing and approach to the surgical management in patients with acute cholecystitis is still a matter of controversy. These Guidelines describe the timing of and the optimal surgical treatment of acute cholecystitis in a question-and-answer format. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
511. Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines.
- Author
-
Masahiro Yoshida, Tadahiro Takada, Yoshifumi Kawarada, Atsushi Tanaka, Yuji Nimura, Harumi Gomi, Masahiko Hirota, Fumihiko Miura, Keita Wada, Toshihiko Mayumi, Joseph S. Solomkin, Steven Strasberg, Henry A. Pitt, Jacques Belghiti, Eduardo de Santibanes, Sheung-Tat Fan, Miin-Fu Chen, Giulio Belli, Serafin C. Hilvano, and Sun-Whe Kim
- Abstract
Abstract??Acute cholecystitis consists of various morbid conditions, ranging from mild cases that are relieved by the oral administration of antimicrobial drugs or that resolve even without antimicrobials to severe cases complicated by biliary peritonitis. Microbial cultures should be performed by collecting bile at all available opportunities to identify both aerobic and anaerobic organisms. Empirically selected antimicrobials should be administered. Antimicrobial activity against potential causative organisms, the severity of the cholecystitis, the patient's past history of antimicrobial therapy, and local susceptibility patterns (antibiogram) must be taken into consideration in the choice of antimicrobial drugs. In mild cases which closely mimic biliary colic, the administration of nonsteroidal anti-inflammatory drugs (NSAIDs) is recommended to prevent the progression of inflammation (recommendation grade A). When causative organisms are identified, the antimicrobial drug should be changed for a narrower-spectrum antimicrobial agent on the basis of the species and their susceptibility testing results. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
512. Results of the Tokyo Consensus Meeting Tokyo Guidelines.
- Author
-
Toshihiko Mayumi, Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Masahiro Yoshida, Miho Sekimoto, Fumihiko Miura, Keita Wada, Masahiko Hirota, Yuichi Yamashita, Masato Nagino, Toshio Tsuyuguchi, Atsushi Tanaka, Harumi Gomi, and Henry A. Pitt
- Abstract
Abstract??A systematic review of references conducted in the process of developing the Guidelines for the Management of Acute Cholangitis and Cholecystitis did not find many high-quality research reports. There were no criteria for diagnosis, severity assessment, or patient transfer, and no established principles of clinical practice guidelines for acute cholangitis and cholecystitis. In order to develop guidelines that would be useful in clinical practice, an understanding of the current status of clinical practice for acute cholangitis and cholecystitis was considered essential. After several open symposia and a survey of these two diseases, we developed and published a Japanese-language version of Evidence-Based Practice Guidelines for the Management of Acute Cholangitis and Cholecystitis. In order to prepare international Guidelines, we had repeated discussions about the draft Guidelines together with international experts, and, following the Consensus Meeting, held on April 1?2, 2006, in Tokyo, with the attendance of 300 world experts in the field, the International Guidelines for the Management of Acute Cholangitis and Cholecystitis were developed. In this article, we outline the comments and opinions given at the International Meeting and how they are reflected in the final version of the Guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
513. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines.
- Author
-
Keita Wada, Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Fumihiko Miura, Masahiro Yoshida, Toshihiko Mayumi, Steven Strasberg, Henry A. Pitt, Thomas R. Gadacz, Markus W. Büchler, Jacques Belghiti, Eduardo de Santibanes, Dirk J. Gouma, Horst Neuhaus, Christos Dervenis, Sheung-Tat Fan, Miin-Fu Chen, Chen-Guo Ker, and Philippus C. Bornman
- Abstract
Abstract??Because acute cholangitis sometimes rapidly progresses to a severe form accompanied by organ dysfunction, caused by the systemic inflammatory response syndrome (SIRS) and/or sepsis, prompt diagnosis and severity assessment are necessary for appropriate management, including intensive care with organ support and urgent biliary drainage in addition to medical treatment. However, because there have been no standard criteria for the diagnosis and severity assessment of acute cholangitis, practical clinical guidelines have never been established. The aim of this part of the Tokyo Guidelines is to propose new criteria for the diagnosis and severity assessment of acute cholangitis based on a systematic review of the literature and the consensus of experts reached at the International Consensus Meeting held in Tokyo 2006. Acute cholangitis can be diagnosed if the clinical manifestations of Charcot''s triad, i.e., fever and/or chills, abdominal pain (right upper quadrant or epigastric), and jaundice are present. When not all of the components of the triad are present, then a definite diagnosis can be made if laboratory data and imaging findings supporting the evidence of inflammation and biliary obstruction are obtained. The severity of acute cholangitis can be classified into three grades, mild (grade I), moderate (grade II), and severe (grade III), on the basis of two clinical factors, the onset of organ dysfunction and the response to the initial medical treatment. ?Severe (grade III)? acute cholangitis is defined as acute cholangitis accompanied by at least one new-onset organ dysfunction. ?Moderate (grade II)? acute cholangitis is defined as acute cholangitis that is unaccompanied by organ dysfunction, but that does not respond to the initial medical treatment, with the clinical manifestations and/or laboratory data not improved. ?Mild (grade I)? acute cholangitis is defined as acute cholangitis that responds to the initial medical treatment, with the clinical findings improved. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
514. Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis.
- Author
-
Tadahiro Takada, Yoshifumi Kawarada, Yuji Nimura, Masahiro Yoshida, Toshihiko Mayumi, Miho Sekimoto, Fumihiko Miura, Keita Wada, Masahiko Hirota, Yuichi Yamashita, Masato Nagino, Toshio Tsuyuguchi, Atsushi Tanaka, Yasutoshi Kimura, Hideki Yasuda, Koichi Hirata, Henry A. Pitt, Steven M. Strasberg, Thomas R. Gadacz, and Philippus C. Bornman
- Abstract
Abstract??There are no evidence-based-criteria for the diagnosis, severity assessment, of treatment of acute cholecysitis or acute cholangitis. For example, the full complement of symptoms and signs described as Charcot''s triad and as Reynolds'' pentad are infrequent and as such do not really assist the clinician with planning management strategies. In view of these factors, we launched a project to prepare evidence-based guidelines for the management of acute cholangitis and cholecystitis that will be useful in the clinical setting. This research has been funded by the Japanese Ministry of Health, Labour, and Welfare, in cooperation with the Japanese Society for Abdominal Emergency Medicine, the Japan Biliary Association, and the Japanese Society of Hepato-Biliary-Pancreatic Surgery. A working group, consisting of 46 experts in gastroenterology, surgery, internal medicine, emergency medicine, intensive care, and clinical epidemiology, analyzed and examined the literature on patients with cholangitis and cholecystitis in order to produce evidence-based guidelines. During the investigations we found that there was a lack of high-level evidence, for treatments, and the working group formulated the guidelines by obtaining consensus, based on evidence categorized by level, according to the Oxford Centre for Evidence-Based Medicine Levels of Evidence of May 2001 (version 1). This work required more than 20 meetings to obtain a consensus on each item from the working group. Then four forums were held to permit examination of the Guideline details in Japan, both by an external assessment committee and by the working group participants (version 2). As we knew that the diagnosis and management of acute biliary infection may differ from country to country, we appointed a publication committee and held 12 meetings to prepare draft Guidelines in English (version 3). We then had several discussions on these draft guidelines with leading experts in the field throughout the world, via e-mail, leading to version 4. Finally, an International Consensus Meeting took place in Tokyo, on 1?2 April, 2006, to obtain international agreement on diagnostic criteria, severity assessment, and management. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
515. Invited commentary
- Author
-
Henry A. Pitt
- Subjects
Surgery - Published
- 1994
- Full Text
- View/download PDF
516. Surgical treatment of choledochal cysts.
- Author
-
Pamela A. Lipsett and Henry A. Pitt
- Subjects
BILIOUS diseases & biliousness ,CYSTS (Pathology) ,GALLBLADDER diseases ,HYPERTROPHY - Abstract
Biliary cystic disease is uncommon in Asia and very rare in Europe and the Americas. Patients with biliary cysts may present as infants, children, or adults. When patients present as adults, they are more likely to have stones in the gallbladder, common duct, or intrahepatic ducts and to present with biliary colic, acute cholecystitis, cholangitis, or gallstone pancreatitis. With increasing age at presentation, the risks of intrahepatic strictures and stones, segmented hepatic atrophy/hypertrophy, secondary biliary cirrhosis, portal hypertension, and biliary malignancy all increase significantly. Factors to be considered when performing surgery on patients with biliary cystic disease include: (1) age, (2) presenting symptoms, (3) cyst type, (4) associated biliary stones, (5) prior biliary surgery, (6) intrahepatic strictures, (7) hepatic atrophy/hypertrophy, (8) biliary cirrhosis, (9) portal hypertension, and (10) associated biliary malignancy. In general, regardless of age, presenting symptoms, biliary stones, prior surgery or other secondary problems, surgery should include cholecystectomy and excision of extrahepatic cyst(s). With respect to the distal bile duct, the surgical principle should be excision of a portion of the intrapancreatic bile duct with care to not injure the pancreatic duct or a long common channel. Resection of the pancreatic head should be reserved for patients with an established malignancy. With respect to the intrahepatic ducts, surgery should be individualized depending on whether (1) both lobes are involved, (2) strictures and stones are present, (3) cirrhosis has developed, or (4) an associated malignancy is localized or metastatic. When the liver is not cirrhotic, hepatic parenchyma should be preserved even when strictures and stones are present. If cirrhosis is advanced, hepatic transplantation may be indicated, but this sequence of events is unusual. If a malignancy has developed, oncologic principles should be followed. Whenever possible, resection of a localized tumor including adjacent hepatic parenchyma and regional lymph nodes should be performed. [ABSTRACT FROM AUTHOR]
- Published
- 2003
517. Gallstones and Laparoscopic Cholecystectomy
- Author
-
Michael F. Sorrell, Anna Mae Diehl, John V. White, Frank G. Moody, Janet D. Elashoff, Bejamin T. Burton, Douglas O. Olsen, Thomas R. Gadacz, Joanne A. P. Wilson, David L. Massanari, Carlos A. Pellegrini, Willis R. Foster, Robert J. Fitzgibbons, Jay H. Hoofnagle, Henry A. Pitt, Keith A. Kelly, Walter J. Hogan, Thomas K. Gadacz, Charles K. McSherry, Alan F. Hofmann, Frank A. Hamilton, Harvey Bernard, Gregory B. Bulkley, L. William Traverso, Nathaniel J. Soper, Eric B. Bass, William H. Hall, James E. Everhart, Don W. Powell, Michael P. Federle, Gary D. Friedman, John H. Ferguson, Sarah C. Kaiser, Steven M. Strasberg, Edward H. Phillips, Joseph B. Petelin, David L. Carr-Locke, Leslie J. Schoenfield, Jeffrey S. T. Barkun, John G. Hunter, Elsa A. Bray, William C. Meyers, William Meyers, Jacques Perissat, David L. Nahrwold, John L. Gollan, and Karl A. Zucker
- Subjects
medicine.medical_specialty ,Rapid weight loss ,Cholesterol ,business.industry ,medicine.medical_treatment ,General Medicine ,Gallstones ,medicine.disease ,Gastroenterology ,Obesity ,Surgery ,Gallbladder motility ,chemistry.chemical_compound ,chemistry ,Older patients ,Internal medicine ,medicine ,Cholecystectomy ,business ,Laparoscopic cholecystectomy - Abstract
APPROXIMATELY 10% to 15% of the adult population or more than 20 million people in the United States have gallstones. It is estimated that there are about 1 million newly diagnosed patients annually. The prevalence is higher in women, in association with multiple pregnancies, obesity, and rapid weight loss, as well as in older patients and in certain ethnic groups. In 1991, approximately 600 000 patients underwent cholecystectomy. As a cause of hospitalization, gallstones are the most common and most costly digestive disease, with an annual estimated overall cost of more than $5 billion. In humans, gallstones are composed principally of cholesterol, with pigment stones occurring less commonly. The formation of cholesterol stones is believed to result from the occurrence of cholesterol supersaturation, accelerated cholesterol crystal nucleation, and impaired gallbladder motility. Stones tend to grow for the first 2 to 3 years, at which point growth tends to stabilize; 85%
- Published
- 1993
- Full Text
- View/download PDF
518. Reply
- Author
-
Eric B. Bass, Earl P. Steinberg, Henry A. Pitt, George P. Saba, Keith D. Lillemoe, David R. Kafonek, Thomas R. Gadacz, Toby A. Gordon, and Gerard F. Anderson
- Subjects
Hepatology ,Gastroenterology - Published
- 1992
- Full Text
- View/download PDF
519. Reoperative Surgery for Periampullary Adenocarcinoma
- Author
-
Keith D. Lillemoe, Gretchen E. McGuire, Henry A. Pitt, Charles J. Yeo, John E. Niederhuber, and John L. Cameron
- Subjects
Adult ,Male ,Reoperation ,Ampulla of Vater ,medicine.medical_specialty ,medicine.medical_treatment ,Common Bile Duct Neoplasms ,Gastric Bypass ,Adenocarcinoma ,Pancreaticoduodenectomy ,Duodenal Neoplasms ,Laparotomy ,Pancreatic cancer ,medicine ,Periampullary cancer ,Humans ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,General surgery ,Retrospective cohort study ,Length of Stay ,Middle Aged ,medicine.disease ,people.cause_of_death ,Surgery ,Pancreatic Neoplasms ,medicine.anatomical_structure ,Periampullary Adenocarcinoma ,Female ,Morbidity ,people ,business - Abstract
• In recent years, the morbidity, mortality, and long-term survival of patients undergoing surgery for periampullary adenocarcinoma have improved. These changes have prompted us to reoperate on patients who have previously undergone pancreatobiliary surgery, many of whom were initially considered to have unresectable lesions. From 1979 to 1990, 38 patients with pancreatic and 17 patients with nonpancreatic periampullary adenocarcinoma underwent reexploratory surgery at The Johns Hopkins Hospital, Baltimore, Md. Thirty-three (60%) of these 55 patients had resection at the time of second laparotomy. Of the 46 patients undergoing reexploratory surgery with an intent to resect, the overall resection rate was 72% (33), 64% (16/25) for pancreatic and 100% for nonpancreatic periampullary adenocarcinoma. Postoperative complications occurred in 21 patients (38%), but only one patient (2%) died following surgery. Mean survivals from reexploratory surgery were 6.9 months for the 22 patients with pancreatic cancer undergoing palliative surgery, 20.5 months for the 16 patients with resectable pancreatic cancer, and 33.0 months for the 17 patients with nonpancreatic periampullary adenocarcinoma undergoing resection. We conclude that in carefully selected patients, reoperative surgery for periampullary cancer (1) provides a significant resection rate, (2) can be performed safely, and (3) offers a chance for long-term survival. ( Arch Surg. 1991;126:1205-1212)
- Published
- 1991
- Full Text
- View/download PDF
520. Erythromycin differentially stimulates motility of the dudoenum, sphincter of oddi, and gallbladder
- Author
-
Keith D. Lillemoe, Steven A. Ahrendt, Howard S. Kaufman, and Henry A. Pitt
- Subjects
medicine.medical_specialty ,business.industry ,Gallbladder ,Motility ,Erythromycin ,General Medicine ,Gastroenterology ,medicine.anatomical_structure ,Internal medicine ,Sphincter of Oddi ,medicine ,Surgery ,business ,medicine.drug - Published
- 1991
- Full Text
- View/download PDF
521. Octreotide inhibits the effect of vasoactive intestinal peptide (VIP) on gallbladder absorption
- Author
-
M.A Silberman, J Bupp-Meko, Steven A. Ahrendt, Keith D. Lillemoe, and Henry A. Pitt
- Subjects
medicine.anatomical_structure ,business.industry ,Gallbladder ,Vasoactive intestinal peptide ,medicine ,Octreotide ,Surgery ,General Medicine ,Pharmacology ,Absorption (chemistry) ,business ,medicine.drug - Published
- 1991
- Full Text
- View/download PDF
522. A History of the Bilioenteric Anastomosis
- Author
-
Henry A. Pitt and Steven A. Ahrendt
- Subjects
medicine.medical_specialty ,business.industry ,Bilioenteric anastomosis ,General surgery ,Anastomosis, Surgical ,History, 19th Century ,History, 20th Century ,Anastomosis ,Surgery ,Intestines ,Biliary Tract Surgical Procedures ,Biliary tract ,medicine ,Animals ,Humans ,Biliary stent ,Digestive tract ,Biliary Tract Surgery ,business ,Biliary tract disease - Abstract
The bilioenteric anastomosis has played an integral role in the surgical management of biliary tract disease during the past century. A wide variety of techniques for suturing a portion of the biliary tract to the digestive tract have been described since von Winiwarter's first cholecystoenterostomy. Many types of biliary stents have also been developed, although their exact role remains controversial. Many advances in preoperative and postoperative care have contributed to the low morbidity and mortality of current reconstructive biliary tract surgery.
- Published
- 1990
- Full Text
- View/download PDF
523. Increased Risk of Gallstones in Children Receiving Total Parenteral Nutrition
- Author
-
Henry A. Pitt, Joel J. Roslyn, Hooshang Kangarloo, William E. Berquist, Linda L. Mann, Lawrence DenBesten, and Marvin E. Ament
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Gallstones ,medicine.disease ,Gastroenterology ,Ileal resection ,Resection ,Increased risk ,Parenteral nutrition ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,Cholecystectomy ,Ultrasonography ,business - Abstract
Twenty-one children receiving long-term total parenteral nutrition were prospectively evaluated for the presence of gallstones. Using ultrasonography, nine children (43%) were found to have cholelithiasis, and five have since undergone cholecystectomy. Only children with ileal disorders or previous resection developed stones. In the select group of patients with ileal disorders or previous resection, the prevalence of stones was 64%, nearly twice that which has been observed in similarly defined adults not receiving total parenteral nutrition. Data from this study suggest that the prolonged administration of parenteral nutrition significantly enhances the risk of gallstone formation already imposed by a previous ileal resection or disorder. Periodic ultrasonograms provide a safe and accurate means of monitoring high-risk patients during and after prolonged total parenteral nutrition therapy.
- Published
- 1983
- Full Text
- View/download PDF
524. Gallbladder Disease in Patients on Long-Term Parenteral Nutrition
- Author
-
Henry A. Pitt, Linda L. Mann, Joel J. Roslyn, Marvin E. Ament, and Lawrence DenBesten
- Subjects
medicine.medical_specialty ,Hepatology ,business.industry ,Incidence (epidemiology) ,Gallbladder disease ,Gastroenterology ,Retrospective cohort study ,Disease ,medicine.disease ,Gallbladder Sludge ,Parenteral nutrition ,Internal medicine ,Cholecystitis ,medicine ,business ,Ileal Diseases - Abstract
Recent anecdotal reports suggest that total parenteral nutrition may be associated with an increased incidence of both acalculous cholecystitis and cholelithiasis. The validity of this association, however, has not been tested in a large population of patients on long-term total parenteral nutrition. Therefore, we assessed the incidence of gallbladder disease among our patients 15 yr and older who had received a minimum of 3 mo of total parenteral nutrition. Of the patients meeting these criteria, 128 were on total parenteral nutrition a mean of 13.5 mo. Nineteen had gallbladder disease before receiving total parenteral nutrition, leaving 109 patients at risk. Of these patients, 25 (23%) developed gallbladder disease after the initiation of total parenteral nutrition. Because of their known propensity for cholelithiasis, 94 of our patients with ileal disorders (Crohn's disease or ileal resection, or both) were considered separately. The 40% incidence of gallbladder disease in these 94 patients was significantly higher than expected from a series of similarly defined patients with ileal disorders not receiving total parenteral nutrition (p
- Published
- 1983
- Full Text
- View/download PDF
525. Cardiovascular and metabolic manifestations of heat stroke and severe heat exhaustion
- Author
-
Anthony M. Costrini, David E. Uddin, Anthony B. Gustafson, and Henry A. Pitt
- Subjects
Male ,Tachycardia ,Hyperthermia ,medicine.medical_specialty ,Myocardial ischemia ,Potassium ,Heat exhaustion ,Water-Electrolyte Imbalance ,chemistry.chemical_element ,Heat Exhaustion ,Electrocardiography ,chemistry.chemical_compound ,Heart Conduction System ,Internal medicine ,medicine ,Humans ,Aspartate Aminotransferases ,Creatine Kinase ,Stroke ,Creatinine ,L-Lactate Dehydrogenase ,biology ,business.industry ,Hemodynamics ,Alanine Transaminase ,Arrhythmias, Cardiac ,General Medicine ,medicine.disease ,Surgery ,Isoenzymes ,chemistry ,Lactates ,Cardiology ,biology.protein ,Creatine kinase ,medicine.symptom ,Energy Metabolism ,business - Abstract
We prospectively studied the clinical, biochemical (including creatine phosphokinase (CPK) isoenzymes) and electrocardiographic features of exertional heat stroke in 13 patients (group 1) and severe heat exhaustion in 14 patients (group 2). Despite initial presentations with severe hyperthermia, tachycardia and hypotension, only one patient with heat stroke had myocardial ischemia. The CPK isoenzymes were not indicative of myocardial damage in any patient. The patients with heat stroke were somewhat more dehydrated than those with heat exhaustion as measured by differences in serum creatinine, sodium and osmolality, and the former (group 1) had a significantly lower initial glucose level (P less than 0.05). Although significant differences in potassium were not observed in the pretreatment samples, at 12 hours the serum potassium was significantly lower in group 1 (P less than 0.05). This suggests that this group may have been more potassium-depleted at the time of heat stroke. Prompt recognition and vigorous therapy were successful in rapidly lowering high temperatures and in preventing serious complications.
- Published
- 1979
- Full Text
- View/download PDF
526. Cholecystokinin Prophylaxis of Parenteral Nutrition-Induced Gallbladder Disease
- Author
-
Jeffrey E. Doty, Vicki Porter-Fink, Henry A. Pitt, and L. DenBesten
- Subjects
medicine.medical_specialty ,Cholesterol ,business.industry ,Gallbladder ,medicine.medical_treatment ,Gallbladder disease ,Acalculous cholecystitis ,medicine.disease ,digestive system ,Hepatic bile ,Gastroenterology ,chemistry.chemical_compound ,medicine.anatomical_structure ,Parenteral nutrition ,chemistry ,Internal medicine ,medicine ,Surgery ,Cholecystectomy ,business ,Cholecystokinin - Abstract
Recent studies indicate that long-term total parenteral nutrition (TPN) induces gallstone formation and acalculous cholecystitis in humans. Cholecystectomy is hazardous for these patients because they frequently have multiple medical problems and have undergone numerous abdominal operations. The present study was designed to develop a method to prevent TPN-induced gallbladder disease. The authors tested the hypothesis that a single daily intravenous infusion of cholecystokinin-octapeptide (CCK-OP) will prevent TPN-induced gallbladder stasis. Eleven prairie dogs received TPN for 10 days. Six of these animals were given a daily infusion of CCK-OP. Control animals were fed ad lib. Each animal's bile salt pool was labeled with intravenous 3H-cholic acid 16 hours prior to acute terminal experiments. The ratio of gallbladder to hepatic bile 3H-cholic acid specific activity (Rsa) provides an index of gallbladder stasis. A Rsa of less than 1.0 indicates gallbladder stasis. TPN animals had a Rsa of 0.54 +/- 0.13 (p less than 0.01 vs. controls), indicating stasis of bile in the gallbladder. Daily CCK-OP infusions resulted in a Rsa of 0.92 +/- 0.10 (p less than 0.05 vs. TPN without CCK-OP), indicating that TPN-induced gallbladder stasis is prevented by daily CCK-OP. Control animals had a Rsa of 1.03 +/- 0.06. The cholesterol saturation indices of gallbladder and hepatic bile were not increased by TPN or CCK-OP. These data indicate that 1) TPN induces gallbladder stasis but does not increase bile lithogenic index; and 2) daily injections of CCK-OP prevent TPN-induced gallbladder stasis.
- Published
- 1985
- Full Text
- View/download PDF
527. Impaired Gallbladder Emptying Before Gallstone Formation in the Prairie Dog
- Author
-
Henry A. Pitt, Stephen L. Kuchenbecker, Jeffrey E. Doty, and Lawrence DenBesten
- Subjects
medicine.medical_specialty ,Hepatology ,biology ,Cholesterol ,business.industry ,Gallbladder ,Gastroenterology ,Gallstones ,Prairie dog ,medicine.disease ,chemistry.chemical_compound ,Sincalide ,medicine.anatomical_structure ,chemistry ,biology.animal ,Internal medicine ,medicine ,Cystic duct ,Gallbladder Emptying ,business ,Cholecystokinin ,medicine.drug - Abstract
Several human and experimental observations suggest that gallbladder stasis is an important link between the hepatic secretion of cholesterol saturated bile and the formation of cholesterol gallstones. In the cholesterol-fed prairie dog model, gallbladder stasis occurs before gallstone formation. In this study we sought to determine the specific defects in extrahepatic biliary physiology responsible for gallbladder stasis in this model. Adult male prairie dogs were fed either a trace cholesterol or a 0.4% cholesterol-enriched diet. In acute terminal experiments; gallbladder contents were examined for cholesterol crystals and gallstones, and gallbladder function was determined at rest and in response to intravenous cholecystokinin-octapeptide. The following alterations in gallbladder function developed concurrently with biliary cholesterol crystallization, but before gallstone formation: (a) decreased gallbladder emptying, (b) increased intragallbladder pressure in response to cholecystokinin-octapeptide, (c) increased cystic duct closing pressure, and (d) increased resistance to outflow through the cystic duct.
- Published
- 1983
- Full Text
- View/download PDF
528. The differing effects of early and chronic cholelithiasis on hepatic bile lithogenicity
- Author
-
Stephen L. Kuchenbecker, Henry A. Pitt, Lawrence DenBesten, James W. Polarek, and Joel J. Roslyn
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Rodentia ,digestive system ,Gastroenterology ,Bile Acids and Salts ,chemistry.chemical_compound ,Cholelithiasis ,Internal medicine ,Enterohepatic Circulation ,medicine ,Cholesterol cholelithiasis ,Animals ,Bile ,Cholecystectomy ,Cholesterol metabolism ,Enterohepatic circulation ,Cholesterol ,business.industry ,Gallbladder ,General Medicine ,Lipid Metabolism ,Hepatic bile ,Gallbladder bile ,Disease Models, Animal ,medicine.anatomical_structure ,Liver ,chemistry ,Chronic Disease ,Surgery ,business - Abstract
The hypothesis that increasing chronicity of cholelithiasis is associated with a progressive alteration of the enterohepatic circulation, resulting in a decrease in bile salt pool size and reversion of hepatic bile composition to a less lithogenic state, was tested in the prairie dog gallstone model. During the early phases of cholesterol cholelithiasis, both hepatic and gallbladder bile were saturated with cholesterol, and the bile salt pool size was normal. As stones became more chronic, the gallbladder was increasingly removed from the enterohepatic circulation, bile salt recycling increased and the pool size decreased. Despite this decrease in pool size and persistence of lithogenic gallbladder bile, hepatic bile composition reverted to a less lithogenic state. These data suggest that the sequelae of functional cholecystectomy are analogous to those of cholecystectomy, In addition, it appears that the liver and gallbladder interact in a dynamic manner, continually influencing the function of each other.
- Published
- 1981
- Full Text
- View/download PDF
529. Does Preoperative Percutaneous Biliary Drainage Reduce Operative Risk or Increase Hospital Cost?
- Author
-
Larry S. Deutsch, Henry A. Pitt, William P. Longmire, Antoinette S. Gomes, Linda L. Mann, and J F Lois
- Subjects
Male ,Risk ,medicine.medical_specialty ,Percutaneous ,Cost-Benefit Analysis ,Gallstones ,Punctures ,Adenocarcinoma ,law.invention ,Random Allocation ,Adenoma, Bile Duct ,Randomized controlled trial ,law ,Preoperative Care ,Humans ,Medicine ,Cholecystectomy ,Prospective Studies ,Prospective cohort study ,Cholestasis ,business.industry ,Hepatobiliary disease ,Perioperative ,Hospital cost ,Length of Stay ,Surgery ,Pancreatic Neoplasms ,Bile Duct Neoplasms ,Liver ,Biliary tract ,Drainage ,Female ,Operative risk ,business ,Research Article - Abstract
Despite recent advances in perioperative support care, surgery for obstructive jaundice is still associated with significant morbidity and mortality. For this reason, preoperative percutaneous transhepatic drainage (PTD) has been recommended for these patients. This method of management, however, has only been supported by retrospective and nonrandomized studies. Therefore, a prospective, randomized study was performed to determine the effect of preoperative PTD on operative mortality, morbidity, hospital stay, and hospital cost. Thirty-day mortality was 8.1% among 37 patients undergoing preoperative PTD, compared to 5.3% for 38 patients who went to surgery without preoperative drainage. Overall morbidity was also slightly, but not significantly, higher in patients who underwent preoperative PTD, (57% versus 53%). However, total hospital stay was significantly longer (p less than 0.005) in the PTD group (31.4 days versus 23.1 days). The cost of this excess hospitalization and the PTD procedure at our university medical center was over +8000 per patient. The authors conclude that preoperative PTD does not reduce operative risk but does increase hospital cost and, therefore, should not be performed routinely.
- Published
- 1985
- Full Text
- View/download PDF
530. Factors affecting mortality in biliary tract surgery
- Author
-
John L. Cameron, Russell G. Postier, Thomas R. Gadacz, and Henry A. Pitt
- Subjects
Adult ,Male ,Risk ,medicine.medical_specialty ,Percutaneous ,Adolescent ,Decompression ,Biliary Tract Diseases ,Postoperative renal failure ,Sepsis ,Postoperative Complications ,Humans ,Medicine ,Upper gastrointestinal ,Aged ,business.industry ,Bile duct ,General Medicine ,Middle Aged ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Bacteremia ,Female ,Kidney Diseases ,Biliary Tract Surgery ,Gastrointestinal Hemorrhage ,business - Abstract
Fifteen clinical and laboratory parameters in 155 consecutive patients having bile duct surgery over a 3 year period were analyzed in an effort to define the factors associated with a poor outcome and to define the subpopulation of patients at greatest risk. Ten of the 15 parameters evaluated were found to correlate significantly (p < 0.05) with hospital mortality. Five or more risk factors correlated significantly with mortality (p < 0.0001) and with postoperative renal failure, bacteremia and upper gastrointestinal hemorrhage (p < 0.005). This risk-factor analysis has the advantages of providing information rapidly and employing only clinical observations and readily available laboratory tests. Patients with five or more risk factors should be considered for preoperative percutaneous transhepatic decompression.
- Published
- 1981
- Full Text
- View/download PDF
531. Effects of cholecystokinin on gallbladder stasis and cholesterol gallstone formation
- Author
-
Lawrence DenBesten, Henry A. Pitt, Joel J. Roslyn, James W. Polarek, and Stephen L. Kuchenbecker
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Gallbladder ,medicine.medical_treatment ,Gallstones ,Prairie dog ,Cholesterol gallstone ,medicine.disease ,digestive system ,Gastroenterology ,medicine.anatomical_structure ,Internal medicine ,biology.animal ,medicine ,Surgery ,Gallbladder Emptying ,Intramuscular injection ,business ,Saline ,Cholecystokinin - Abstract
Recent studies suggest an etiologic role for gallbladder stasis in the genesis of cholesterol gallstones. The effect of periodic gallbladder emptying on stone prevention is not clear. Using the prairie dog model, we tested the hypothesis that daily cholecystokinin-octapeptide (CCK-OP) prevents gallbladder stasis and cholesterol gallstone formation. Prairie dogs were fed either a control or a 0.4% cholesterol-enriched chow for 6 weeks. Cholesterol-fed animals received a daily intramuscular injection of either saline, CCK-OP, 0.2 μg/kg or CCK-OP, 1.0 μg/kg. Gallbladder bile lithogenic index (LI), bile salt pool size (BSPS), and the degree of radioisotope equilibration between gallbladder and hepatic bile (Rsa-an index of stasis) were determined. The more physiologic dose of CCK-OP (0.2) significantly reduced BSPS and bile lithogenicity, prevented stasis and reduced the incidence of gallstones. Our data suggest that (1) periodic gallbladder emptying decreases bile lithogenicity, prevents stasis, and reduces the incidence of cholelithiasis, (2) stasis is essential to gallstone formation and (3) daily physiologic doses of CCK-OP may be useful for gallstone prophylaxis in high-risk patients.
- Published
- 1981
- Full Text
- View/download PDF
532. Benign Postoperative Biliary Strictures
- Author
-
Stephen L. Kaufman, Henry A. Pitt, Robert I. White, John L. Cameron, and JoAnn Coleman
- Subjects
Male ,Surgical repair ,medicine.medical_specialty ,Cholestasis ,business.industry ,Middle Aged ,Catheterization ,Surgery ,Balloon dilatation ,Postoperative Complications ,Cholelithiasis ,Humans ,Medicine ,Female ,business ,Hospital stay ,Cholangiography ,Research Article ,Follow-Up Studies - Abstract
At The Johns Hopkins Hospital from 1979 through 1987, 42 patients had 45 procedures for benign postoperative biliary strictures. Three patients were managed with both surgery and balloon dilatation. Twenty-five patients underwent surgical repair with Roux-Y choledocho- or hepaticojejunostomy with postoperative transhepatic stenting for a mean of 13.8 +/- 1.3 months. Twenty patients had balloon dilatation a mean of 3.9 times and were stented transhepatically for a mean of 13.3 +/- 2.0 months. The two groups were similar with respect to multiple parameters that might have influenced outcome. Mean length of follow-up was 57 +/- 7 and 59 +/- 6 months for surgery and balloon dilatation, respectively. No patients died after any of the procedures. The same definition of a successful outcome was applied to both groups and was achieved in 88% of the surgical and in only 55% of the balloon dilatation patients (p less than 0.02). Significant hemobilia occurred more often with balloon dilatation (20% vs. 4%, p less than 0.02). The total hospital stay and cost of balloon dilatation was not significantly different from surgery. We conclude that surgical repair of benign postoperative strictures results in fewer problems that require further therapy. Nevertheless balloon dilatation is an alternative for patients who are at high risk or who are unwilling to undergo another operation.
- Published
- 1989
- Full Text
- View/download PDF
533. Bullous Pemphigoid and Ulcerative Colitis
- Author
-
David J. Hardy, Henry A. Pitt, A. Razzaque Ahmed, Richard P. Kaplan, and Edward J. Feldman
- Subjects
Adult ,Pemphigoid ,Pathology ,medicine.medical_specialty ,Dermatology ,Surgical specimen ,Basement Membrane ,Resection ,Crohn Disease ,Pemphigoid, Bullous ,Humans ,Medicine ,Colitis ,Direct fluorescent antibody ,Skin Diseases, Vesiculobullous ,integumentary system ,biology ,business.industry ,Complement C3 ,medicine.disease ,Ulcerative colitis ,digestive system diseases ,Immunoglobulin G ,biology.protein ,Colitis, Ulcerative ,Female ,Bullous pemphigoid ,Antibody ,business - Abstract
A 21-year-old white woman, who had ulcerative colitis for 14 years, developed generalized severe bullous pemphigoid. Following the resection of her colon, her skin showed marked clinical improvement, but this was only temporary. Direct immunofluorescence was performed on the surgical specimen and no antibodies (BMZ) to colonic mucosal cells were evident. Anti-basement membrane zone antibodies were found on direct and indirect immunofluorescent studies and have persisted. Sera from 15 patients with ulcerative colitis and 11 patients with Crohn's disease, evaluated for the presence of an anti-basement membrane zone antibody did not contain any demonstrable levels of anti-BMZ antibodies. The co-existence of ulcerative colitis and bullous pemphigoid is more likely incidental rather than etiopathologic.
- Published
- 1982
- Full Text
- View/download PDF
534. Neuropeptide Y: A candidate neurotransmitter for biliary motility
- Author
-
Henry A. Pitt, Keith D. Lillemoe, and Thomas H. Webb
- Subjects
Male ,medicine.medical_specialty ,Rodentia ,digestive system ,Internal medicine ,Sphincter of Oddi ,Pressure ,medicine ,Animals ,Neuropeptide Y ,Biliary Tract ,Infusions, Intravenous ,Cholecystokinin ,Neurotransmitter Agents ,Gallbladder Fundus ,business.industry ,Gallbladder ,Neuropeptide Y receptor ,medicine.anatomical_structure ,Endocrinology ,Peptide YY ,Duodenum ,Surgery ,business ,Perfusion ,Muscle Contraction - Abstract
Neuropeptide Y (NPY) is a recently discovered polypeptide found in neurons throughout the gastrointestinal tract and in especially high concentrations in the biliary tree. This study was designed to test the functional significance of these high concentrations in the biliary tree by determining the effect of intravenous NPY on sphincter of Oddi and gallbladder motility. In adult male prairie dogs a side-hole, pressure-monitored perfusion catheter was placed through a choledochotomy into the duodenum and positioned in the sphincter of Oddi. A perfusion catheter was also placed in the gallbladder fundus. Sphincter of Oddi and gallbladder pressures were recorded before and during intravenous infusions of NPY at doses of 10, 100, and 500 ng/kg/min. Each dose was administered to seven separate animals. No effects were seen at the 10 or 100 ng/kg/min doses. NPY at the 500 ng/kg/min dose significantly increased sphincter of Oddi phasic wave frequency, amplitude, and motility index (MI = F X A). In addition, gallbladder pressure was significantly increased after 20 min of intravenous infusion of NPY at the 500 ng/kg/min dose. No significant changes in blood pressure were noted. These data suggest that in the prairie dog, systemic intravenous infusion of NPY significantly increases sphincter of Oddi phasic wave activity and gallbladder pressure. These findings are similar to those observed with intravenous cholecystokinin but opposite of those seen with peptide YY in this species. We hypothesize that neuropeptide Y may be an important neurotransmitter or neuromodulator regulating bile flow.
- Published
- 1988
- Full Text
- View/download PDF
535. Gastrosphincter of Oddi reflex
- Author
-
Henry A. Pitt, Keith D. Lillemoe, and Thomas H. Webb
- Subjects
Atropine ,Male ,Ampulla of Vater ,medicine.medical_specialty ,Motility ,Gastric Dilatation ,digestive system ,Gastroenterology ,Internal medicine ,Reflex ,Sphincter of Oddi ,Pressure ,medicine ,Animals ,Pancreatic Exocrine Secretion ,business.industry ,Gastric distension ,Gallbladder ,digestive, oral, and skin physiology ,Sciuridae ,General Medicine ,medicine.anatomical_structure ,Gastric acid ,Peristalsis ,Surgery ,medicine.symptom ,business ,medicine.drug - Abstract
Summary Gastric distention is known to stimulate gallbladder contraction as well as gastric acid and pancreatic exocrine secretion by way of neural reflexes. Gallbladder distention, in turn, has been shown to affect sphincter of Oddi motility. Since gastric distention may accompany endoscopic or operative biliary manometry, we tested the hypothesis that gastric distension alters sphincter of Oddi motility. In the prairie dog model, gastric distention with acid (0.1 M hydrochloric acid, pH 1.3) and alkaline (10−5 sodium hydroxide, pH 8.8) isotonic saline solutions both resulted in significant increases in sphincter of Oddi phasic wave frequency, amplitude, and motility index. Similarly, gallbladder pressure increased during both distention periods, thus confirming the previously described pylorocholecystic reflex. These responses were abolished by systemic pretreatment with atropine, suggesting that this reflex is cholinergically mediated. These data suggest the presence of a gastrosphincter of Oddi reflex where-by gastric distention stimulates sphincter of Oddi motility in the prairie dog. We conclude that gastric distention is an important variable to be controlled when performing endoscopic or operative sphincter of Oddi manometry.
- Published
- 1988
- Full Text
- View/download PDF
536. Role of gallbladder mucus in the pathogenesis of cholesterol gallstones
- Author
-
Lawrence DenBesten, Stephen L. Kuchenbecker, Vicki Porter-Fink, Henry A. Pitt, and Jeffrey E. Doty
- Subjects
Male ,medicine.medical_specialty ,Cholesterol gallstones ,Rodentia ,Models, Biological ,Gastroenterology ,Cholesterol, Dietary ,Pathogenesis ,chemistry.chemical_compound ,Cholelithiasis ,Internal medicine ,medicine ,Animals ,Bile ,Secretion ,Cholesterol ,business.industry ,Gallbladder ,General Medicine ,Mucus ,Gallbladder bile ,medicine.anatomical_structure ,Liver ,chemistry ,Cystic duct ,lipids (amino acids, peptides, and proteins) ,Surgery ,business - Abstract
Recent observations indicate that the hepatic secretion of lithogenic bile, gallbladder mucus hypersecretion, and gallbladder stasis are all critical factors in the pathogenesis of cholesterol gallstones. Using the prairie dog gallstone model, we investigated the interaction of these factors and the sequence in which they develop. The results of this study indicated that (1) gallbladder bile mucus concentration is elevated before cholesterol precipitation and increases progressively with the formation of cholesterol crystals, (2) cystic duct resistance increases in the presence of cholesterol crystals, and (3) agglomerates of cholesterol crystals, but not fine, sonicated crystals increase cystic duct resistance. We conclude that these alterations trigger a self-perpetuating cycle of mucus hypersecretion, cholesterol crystallization, and gallbladder stasis which culminates in the formation of cholesterol gallstones.
- Published
- 1983
- Full Text
- View/download PDF
537. Factors influencing outcome in patients with postoperative biliary strictures
- Author
-
Ronald K. Tompkins, William P. Longmire, Sandra K. Parapatis, Henry A. Pitt, and Toshimitsu Miyamoto
- Subjects
Adult ,Reoperation ,medicine.medical_specialty ,Time Factors ,Biliary Tract Diseases ,medicine.medical_treatment ,Portacaval shunt ,Cicatrix ,Gastrectomy ,Methods ,Hepatectomy ,Humans ,Medicine ,Cholecystectomy ,In patient ,Favorable outcome ,Good outcome ,Inverse correlation ,Aged ,Portacaval Shunt, Surgical ,business.industry ,Age Factors ,Stent ,Prostheses and Implants ,General Medicine ,Middle Aged ,Silastic ,Prognosis ,Surgery ,surgical procedures, operative ,Radiology ,business ,Follow-Up Studies ,Early referral - Abstract
We reviewed our experience from 1955 to 1979 with benign postoperative biliary strictures to determine which factors were associated with a favorable outcome. Patients operated on from 1970 to 1979 were significantly more likely (p less than 0.01) to achieve a good result (86 percent) than were patients undergoing surgery between 1955 and 1969 (68 percent). An inverse correlation (r = -0.96, p less than 0.05) was present between the number of previous repairs and the percentage of good results. Patients referred without a previous repair were most likely to achieve a good result (86 percent). Roux-Y jejunal reconstructions were associated with the best results (p less than 0.01). In recent years Silastic transhepatic stents were used in 20 patients with hilar strictures; 18 (90 percent) achieved good results. Patients stented for the shortest period (less than 1 month) were less likely to achieve a good outcome than those stented for longer periods (p less than 0.025). Patients with difficult hilar strictures who were stented for more than 9 months were more likely to have a good result if a changeable Silastic transhepatic stent was employed (p less than 0.01). This analysis suggests that early referral, Roux-Y jejunal reconstruction, judicious use of Silastic transhepatic stents, and prolonged stenting of hilar strictures will improve the outlook in patients with postoperative biliary strictures.U
- Published
- 1982
- Full Text
- View/download PDF
538. Resection of Hepatic Duct Bifurcation and Transhepatic Stenting for Sclerosing Cholangitis
- Author
-
H. F. Herlong, J. Coleman, John L. Cameron, Michael J. Zinner, Henry A. Pitt, Steven Kaufman, and John K. Boitnott
- Subjects
Adult ,Male ,medicine.medical_specialty ,Cirrhosis ,Cholangitis ,Biliary cirrhosis ,medicine.medical_treatment ,Hepatic Duct, Common ,Liver transplantation ,Gastroenterology ,Catheterization ,Cholangiography ,Internal medicine ,medicine ,Humans ,Cholecystectomy ,Aged ,Sclerosis ,medicine.diagnostic_test ,business.industry ,Middle Aged ,Silastic ,Jaundice ,medicine.disease ,Dilatation ,Surgery ,Liver biopsy ,Chronic Disease ,Silicone Elastomers ,Female ,medicine.symptom ,Hepatic fibrosis ,business ,Research Article - Abstract
Thirty-one patients with sclerosing cholangitis underwent reconstruction of their hepatic duct bifurcation and long-term stenting between 1980 and 1987. Indications for surgery were persistent jaundice in 29 and recurrent cholangitis in two. The mean serum bilirubin level before surgery was 10.4 mg/dl. Liver biopsy revealed that 26 patients had varying degrees of hepatic fibrosis, and five patients had progressed to secondary biliary cirrhosis. In 29 patients the major obstructive duct disease was at or near the hepatic duct bifurcation, and in two patients it was in the distal common duct. The operative procedure consisted of: (1) excision of the hepatic duct bifurcation and extrahepatic biliary tree, (2) dilatation of the intrahepatic ducts, (3) insertion of Silastic transhepatic biliary stents, and (4) bilateral hepaticojejunostomies. Two of the five patients (40%) with cirrhosis died after surgery. In contrast, only one of 26 patients (3.9%) with hepatic fibrosis died after operation. The 1-, 3-, and 5-year actuarial survival rates for patients with cirrhosis were 20%, 20%, and 20%, respectively. The only long-term survivor underwent a liver transplant. The 1-, 3-, and 5-year actuarial survival rates for patients with hepatic fibrosis were 92%, 87%, and 71%, respectively. In addition, the mean serum bilirubin levels of patients with hepatic fibrosis at 1, 2, 3, 4, and 5 years were 3.4 mg/dl, 2.9 mg/dl, 4.0 mg/dl, 5.4 mg/dl, and 4.3 mg/dl, respectively. Two of the long-term survivors subsequently underwent a liver transplant. Patients with sclerosing cholangitis, persistent jaundice, and biliary cirrhosis should be referred for consideration of liver transplantation. However, in the absence of biliary cirrhosis, if the major obstructive disease is at the hepatic duct bifurcation, primary biliary reconstruction and long-term stenting should be considered.
- Published
- 1988
- Full Text
- View/download PDF
539. Statement on guidelines for total parenteral nutrition
- Author
-
Henry A. Pitt and James V. Sitzmann
- Subjects
medicine.medical_specialty ,Transplant surgery ,Parenteral nutrition ,Physiology ,Statement (logic) ,business.industry ,Family medicine ,Gastroenterology ,Medicine ,Clinical nutrition ,business ,Patient care - Abstract
This is one of a series of clinical guidelines. They represent a consensus statement dealing with optimum patient care in significant clinical areas. The statement has been prepared by the Patient Care Committee, with the advice of other experts and with peer review. As with all such guidelines, they should be interpreted in a nondogmatic manner, so as not to exclude other therapies or opinions in any particular situation. Based on present knowledge, limited at times, future modifications or other changes in these guidelines may be necessary.
- Published
- 1989
- Full Text
- View/download PDF
540. Prophylactic Antibiotics in Vascular Surgery
- Author
-
HENRY A. PITT, RUSSELL G. POSTER, A. L. WILLIAM, null MACGOWAN, LINDA W. FRANK, ANDREW J. SURMAK, JAMES V. SITZMAN, and DAVID BOUCHIER-HAYES
- Subjects
Risk ,medicine.medical_specialty ,medicine.drug_class ,Antibiotics ,Groin ,law.invention ,Random Allocation ,Randomized controlled trial ,law ,medicine ,Humans ,Surgical Wound Infection ,Prospective Studies ,Prospective cohort study ,Cephradine ,Clinical Trials as Topic ,business.industry ,Bacterial Infections ,Perioperative ,Vascular surgery ,Anti-Bacterial Agents ,Blood Vessel Prosthesis ,Surgery ,Clinical trial ,medicine.anatomical_structure ,Anesthesia ,business ,Vascular Surgical Procedures ,Research Article - Abstract
A prospective, randomized, blinded study was performed to determine whether prophylactic antibiotics would reduce the incidence of infection in peripheral vascular surgery and whether the route of antibiotic administration was important. Patients undergoing a vascular procedure with a groin incision were allocated to one of four groups with respect to prophylactic antibiotics. Group I received no antibiotic. Group II had topical cephradine instilled in their incisions prior to closure. Group III received a 24-hour perioperative course of intravenous cephradine, and Group IV received both topical and intravenous cephradine. Groin and abdominal incisional infections were significantly reduced (p < 0.01) among patients who received prophylactic antibiotics by either the topical, systemic, or combined routes of administration. No significant differences were noted among the three antibiotic groups. Profundoplasty, femoral embolectomy, and femoral aneurysm repair were each associated with an increased incidence of infection (p < 0.01). Other risk factors were only important in patients not receiving antibiotics. Either intraoperative topical antibiotics or perioperative systemic antibiotics prevent infection in peripheral vascular surgery, but antibiotic administration by both routes is unnecessary.
- Published
- 1980
- Full Text
- View/download PDF
541. Management of hepatic echinococcosis in Southern California
- Author
-
Henry A. Pitt, John Korzellus, and Ronald K. Tompkins
- Subjects
Adult ,Male ,Echinococcosis, Hepatic ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Secondary infection ,Cystectomy ,Liver Function Tests ,Axial tomography ,medicine ,Humans ,Cyst ,Child ,Aged ,Skin Tests ,Endoscopic retrograde cholangiopancreatography ,medicine.diagnostic_test ,business.industry ,General Medicine ,Middle Aged ,Marsupialization ,medicine.disease ,Hepatic Echinococcosis ,Surgery ,medicine.anatomical_structure ,Child, Preschool ,Duodenum ,Female ,Tomography, X-Ray Computed ,business ,Cholangiography - Abstract
In the United States, hydatid disease of the liver is being seen with increasing frequency in persons who have immigrated from endemic areas. At the University of California, Los Angeles Medical Center, 24 patients with 46 echinococcal cysts were managed over a 26 year period. Seven patients (29 percent) had cyst rupture: into the lungs in three patients, the biliary tree in two, and the peritoneum and duodenum in one patient each. In recent years, serologic tests, computerized axial tomography, and endoscopic retrograde cholangiopancreatography have greatly aided the diagnosis and management of these patients. Four patients were treated nonoperatively, and 20 patients (with a total of 41 cysts) underwent operation. Cyst management included partial cystectomy in 19 patients, complete cystectomy in 18 patients, left hepatic lobectomy in 2 patients, and marsupialization and removal of hepatic debris from the common duct in 1 patient each. Primary cyst closure, omental packing, external drainage, or cystojejunostomy was individualized on the basis of cyst size, location, secondary infection or rupture, and communication with the biliary tree. Morbidity, including two temporary external biliary fistulas, occurred in eight patients (40 percent) but could not be related to cyst management or preoperative rupture. No deaths occurred in this series.
- Published
- 1986
- Full Text
- View/download PDF
542. Pancreatectomy risk calculator: an ACS-NSQIP resource
- Author
-
Purvi Parikh, Clifford Y. Ko, Karl Y. Bilimoria, Mark E. Cohen, Mira Shiloach, Henry A. Pitt, and Bruce L. Hall
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adverse outcomes ,medicine.medical_treatment ,MEDLINE ,Risk Assessment ,law.invention ,Resource (project management) ,law ,Risk Factors ,medicine ,Odds Ratio ,Humans ,Registries ,Intensive care medicine ,Societies, Medical ,Aged ,Quality Indicators, Health Care ,pancreatic resections ,Hepatology ,business.industry ,Patient Selection ,Gastroenterology ,Odds ratio ,Original Articles ,Middle Aged ,ACS-NSQIP ,United States ,Acs nsqip ,Logistic Models ,Outcome and Process Assessment, Health Care ,Calculator ,Pancreatectomy ,Female ,risk calculator ,pancreatectomy ,business ,Risk assessment - Abstract
BackgroundThe morbidity of pancreatoduodenectomy remains high and the mortality may be significantly increased in high-risk patients. However, a method to predict post-operative adverse outcomes based on readily available clinical data has not been available. Therefore, the objective was to create a ‘Pancreatectomy Risk Calculator’ using the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) database.MethodsThe 2005–2008 ACS-NSQIP data on 7571 patients undergoing proximal (n= 4621), distal (n= 2552) or total pancreatectomy (n= 177) as well as enucleation (n= 221) were analysed. Pre-operative variables (n= 31) were assessed for prediction of post-operative mortality, serious morbidity and overall morbidity using a logistic regression model. Statistically significant variables were ranked and weighted to create a common set of predictors for risk models for all three outcomes.ResultsTwenty pre-operative variables were statistically significant predictors of post-operative mortality (2.5%), serious morbidity (21%) or overall morbidity (32%). Ten out of 20 significant pre-operative variables were employed to produce the three mortality and morbidity risk models. The risk factors included age, gender, obesity, sepsis, functional status, American Society of Anesthesiologists (ASA) class, coronary heart disease, dyspnoea, bleeding disorder and extent of surgery.ConclusionThe ACS-NSQIP ‘Pancreatectomy Risk Calculator’ employs 10 easily assessable clinical parameters to assist patients and surgeons in making an informed decision regarding the risks and benefits of undergoing pancreatic resection. A risk calculator based on this prototype will become available in the future as on online ACS-NSQIP resource.
- Full Text
- View/download PDF
543. Diminished gallbladder motility in rotund leptin‐resistant obese mice
- Author
-
Khoi Q. Tran, Shannon J. Graewin, Debbie Swartz-Basile, Henry A. Pitt, Attila Nakeeb, Jurgen K. Naggert, and Kuen Ho Lee
- Subjects
medicine.medical_specialty ,Article ,Contractility ,chemistry.chemical_compound ,Internal medicine ,medicine ,gallbladder ,Cholecystokinin ,Leptin receptor ,Hepatology ,Cholesterol ,business.industry ,Gallbladder ,Leptin ,digestive, oral, and skin physiology ,Gastroenterology ,Gallstones ,Neuropeptide Y receptor ,medicine.disease ,Endocrinology ,medicine.anatomical_structure ,chemistry ,motility ,diabetes mellitus ,gallstones ,business ,hormones, hormone substitutes, and hormone antagonists - Abstract
Background. Obesity is a risk factor for cholesterol gallstone formation, but the pathogenesis of this phenomenon remains unclear. Most human obesity is associated with diabetes and leptin-resistance. Previous studies from this laboratory have demonstrated that diabetic leptin-resistant (Lepdb) obese mice have low biliary cholesterol saturation indices, enlarged gallbladders and diminished gallbladder response to neurotransmitters. Recently, a novel leptin-resistant mouse strain Leprdb-rtnd (Rotund) has been discovered. Rotund mice are also obese, diabetic, and have an abnormal leptin receptor. Therefore, we tested the hypothesis that leptin-resistant obese Rotund mice would have large gallbladders and reduced biliary motility. Methods. Eight-week-old control (C57BL/6J, N=12) and Rotund leptin-resistant (Leprdb-rnd, N=9) mice were fed a non- lithogenic diet for four weeks. Animals were fasted and underwent cholecystectomy. Gallbladder volumes were recorded, and contractile responses (N/cm2) to acetylcholine (10−5 M), Neuropeptide Y (10−8,−7,−6 M), and cholecystokinin (10−10,−9,−8,−7 M) were measured. Results were analyzed using the Mann-Whitney Rank Sum Test. Results. Compared to control mice, Rotund mice had larger body weights, higher serum glucose levels, and greater gallbladder volumes (p
- Full Text
- View/download PDF
544. ACS-NSQIP has the potential to create an HPB-NSQIP option
- Author
-
Thomas A. Aloia, Henry A. Pitt, J. Michael Henderson, Sean J. Mulvihill, Molly Kilbane, Steven M. Strasberg, Nicholas J. Zyromski, Timothy M. Pawlik, and Elijah Dixon
- Subjects
medicine.medical_specialty ,Hepatology ,business.industry ,hepaticojejunostomy ,medicine.medical_treatment ,Mortality rate ,General surgery ,Gastroenterology ,Original Articles ,cholecystectomy ,medicine.disease ,Surgery ,Clinical trial ,hepatectomy ,Weight loss ,quality ,Diabetes mellitus ,Pancreatectomy ,Ascites ,medicine ,Cholecystectomy ,medicine.symptom ,Hepatectomy ,pancreatectomy ,business - Abstract
BackgroundThe American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) was started in 2004. Presently, 58% of the 198 hospitals participating in ACS-NSQIP are academic or teaching hospitals. In 2008, ACS-NSQIP initiated a number of changes and made risk-adjusted data available for use by participating hospitals. This analysis explores the ACS-NSQIP database for utility in developing hepato-pancreato-biliary (HPB) surgery-specific outcomes (HPB-NSQIP).MethodsThe ACS-NSQIP Participant Use File was queried for patient demographics and outcomes for 49 HPB operations from 1 January 2005 through 31 December 2007. The procedures included six hepatic, 16 pancreatic and 23 complex biliary operations. Four laparoscopic or open cholecystectomy operations were also studied. Risk-adjusted probabilities for morbidity and mortality were compared with observed rates for each operation.ResultsDuring this 36-month period, data were accumulated on 9723 patients who underwent major HPB surgery, as well as on 44189 who received cholecystectomies. The major HPB operations included 2847 hepatic (29%), 5074 pancreatic (52%) and 1802 complex biliary (19%) procedures. Patients undergoing hepatic resections were more likely to have metastatic disease (42%) and recent chemotherapy (7%), whereas those undergoing complex biliary procedures were more likely to have significant weight loss (20%), diabetes (13%) and ascites (5%). Morbidity was high for hepatic, pancreatic and complex biliary operations (20.1%, 32.4% and 21.2%, respectively), whereas mortality was low (2.3%, 2.7% and 2.7%, respectively). Compared with laparoscopic cholecystectomy, the open operation was associated with higher rates of morbidity (19.2% vs. 6.0%) and mortality (2.5% vs. 0.3%). The ratios between observed and expected morbidity and mortality rates were
- Full Text
- View/download PDF
545. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma
- Author
-
Henry A. Pitt, Thomas J. Howard, C. Max Schmidt, Nicholas J. Zyromski, Aakash Chauhan, Keith D. Lillemoe, Chad G. Ball, Attila Nakeeb, and Michael G. House
- Subjects
medicine.medical_specialty ,Hepatology ,Proportional hazards model ,business.industry ,medicine.medical_treatment ,Gastroenterology ,Retrospective cohort study ,morbidity ,Bile Duct Neoplasm ,outcomes ,Post operative morbidity ,mortality ,Resection ,Surgery ,medicine ,resection ,Hepatectomy ,business ,cholangiocarcinoma ,Survival rate ,Chi-squared distribution - Abstract
BackgroundThe purpose of the present study was to demonstrate that post-operative morbidity (PM) associated with resections of hilar cholangiocarcinoma (HCCA) is associated with short- and long-term patient survival.MethodsBetween 1998 and 2008, 51 patients with a median age of 64 years underwent resection for HCCA at a single institution. Associations between survival and clinicopathologic factors, including peri- and post-operative variables, were studied using univariate and multivariate models.ResultsSeventy-six per cent of patients underwent major hepatectomy with resection of the extrahepatic bile ducts. The 30- and 90-day operative mortality was 10% and 12%. The overall incidence of PM was 69%, with 68% of all PM as major (Clavien grades III–V). No difference in operative blood loss or peri-operative transfusion rates was observed for patients with major vs. minor or no PM. Patients with major PM received adjuvant chemotherapy less frequently than patients with minor or no complications 29% vs. 52%, P= 0.15. The 1-, 3- and 5-year overall (OS) and disease-specific survival (DSS) rates for all patients were 65%, 36%, 29% and 77%, 46%, 35%, respectively. Using univariate and multivariate analysis, margin status (27% R1), nodal metastasis (35% N1) and major PM were associated with OS and DSS, P < 0.01. Major PM was an independent factor associated with decreased OS and DSS [hazard ratio (HR) = 3.6 and 2.8, respectively, P < 0.05]. The median DSS for patients with major PM was 14 months compared with 40 months for patients who experienced minor or no PM, P < 0.01.ConclusionExtensive operations for HCCA can produce substantial post-operative morbidity. In addition to causing early mortality, major post-operative complications are associated with decreased long-term cancer-specific survival after resection of HCCA.
- Full Text
- View/download PDF
546. Biliary lipids and cholesterol crystal formation in leptin-deficient obese mice
- Author
-
Khoi Q. Tran, Deborah A. Swartz-Basile, Attila Nakeeb, Seong Ho Choi, Henry A. Pitt, Carol L. Svatek, and Matthew I. Goldblatt
- Subjects
medicine.medical_specialty ,obesity ,Motility ,Blood lipids ,bile ,Article ,chemistry.chemical_compound ,strain ,In vivo ,Internal medicine ,Diabetes mellitus ,medicine ,gallbladder ,Hepatology ,diabetes ,business.industry ,Cholesterol ,Leptin ,Gallbladder ,Gastroenterology ,cholesterol ,medicine.disease ,Obesity ,Endocrinology ,medicine.anatomical_structure ,chemistry ,lipids (amino acids, peptides, and proteins) ,business - Abstract
Background. Obesity is often associated with increased biliary cholesterol secretion resulting in cholesterol gallstone formation. We have previously demonstrated that leptin-deficient C57Bl/6J Lep ob obese mice have abnormal biliary motility and are prone to cholesterol crystal formation. In addition, others have demonstrated that leptin-deficient mice when fed a lithogenic diet for eight weeks are not prone to gallstone formation. However, the biliary lipid and in vivo cholesterol crystal response of homozygous and heterozygous leptin-deficient mice to four weeks on a lithogenic diet has not been studied. Therefore, we tested the hypothesis that lithogenic diets influence gallbladder bile composition, serum lipids and cholesterol crystal formation in homozygous and heterozygous leptin-deficient mice compared to normal lean controls. Methods. 319 female lean control mice, 280 heterozygous lep ob obese mice and 117 homozygous lep ob obese mice were studied. Mice were fed either a lithogenic or control non-lithogenic chow diet for four weeks. Gallbladder volumes were measured, and bile was pooled to calculate cholesterol saturation indices. Serum cholesterol, glucose, and leptin levels were determined. Hepatic fat vacuoles were counted, and bile was observed microscopically for cholesterol crystal formation. Results. The lithogenic diet and mouse strain influenced body and liver weights, gallbladder volume, cholesterol crystal formation, serum cholesterol, glucose and leptin levels and hepatic fat vacuole numbers. However, only diet, not strain, altered biliary cholesterol saturation. Conclusion. The association among obesity, leptin, and gallstone formation may be primarily related to altered gallbladder motility and cholesterol crystal formation and only secondarily to biliary cholesterol saturation.
- Full Text
- View/download PDF
547. Invited commentary
- Author
-
Henry A. Pitt
- Subjects
Surgery - Published
- 1980
- Full Text
- View/download PDF
548. Primary sclerosing cholangitis: a heterogenous disease
- Author
-
Henry A. Pitt, Ronald K. Tompkins, H. Hilary Thompson, and William P. Longmire
- Subjects
medicine.medical_specialty ,business.industry ,Cholangitis ,Biliary Tract Diseases ,Acute necrotizing ,Disease ,medicine.disease ,Inflammatory bowel disease ,Gastroenterology ,Ulcerative colitis ,Primary sclerosing cholangitis ,Natural history ,Radiography ,Distal Common Bile Duct ,Internal medicine ,medicine ,Etiology ,Humans ,Surgery ,business ,Biliary Tract ,Research Article - Abstract
The clinical, radiologic and pathologic features of 37 patients diagnosed as having primary sclerosing cholangitis (PSC) were reviewed. Sixty-two per cent were men, and 35% had ulcerative colitis. The patients demonstrated considerable variability in their natural history and pathology. It appeared that they could be divided into four fairly distant groups (1) sclerosing cholangitis affecting primarily the distal common bile duct; (2) sclerosing cholangitis occurring soon after an attack of acute necrotizing cholangitis; (3) chronic diffuse sclerosing cholangitis; and (4) chronic diffuse sclerosing cholangitis associated with inflammatory bowel disease. It is suggested that the patients in these groups may have different etiologies, may respond to different treatment regimes, and may have different prognoses.
- Published
- 1982
549. Carbohydrate diet-induced calcium bilirubinate sludge and pigment gallstones in the prairie dog
- Author
-
Henry A. Pitt, Joel J. Roslyn, Lawrence DenBesten, and R. L. Conter
- Subjects
Male ,medicine.medical_specialty ,Sucrose ,Bilirubin ,chemistry.chemical_element ,Biology ,Calcium ,chemistry.chemical_compound ,Cholelithiasis ,Internal medicine ,medicine ,Dietary Carbohydrates ,Animals ,Bile ,Biliary sludge ,Hepatobiliary disease ,Gallbladder ,Sciuridae ,Gallstones ,Pigments, Biological ,Carbohydrate ,medicine.disease ,Disease Models, Animal ,Endocrinology ,chemistry ,Biliary tract ,Surgery - Abstract
Epidemiologic studies suggest that consumption of diets rich in carbohydrates may, in part, be responsible for the increasing incidence of pigment gallstone disease. The mechanism by which these dietary components lead to pigment stone formation remains obscure. Furthermore, investigative efforts in this area have been hampered by the lack of a suitable animal model. The present study was undertaken to study the role of complex carbohydrates in pigment gallstone formation in the prairie dog. Two groups of eight animals each were maintained on either a control, nonlithogenic chow, or a high carbohydrate (35% sucrose, 32% rich starch) diet for 2 months. Neither crystals nor gallstones were observed in any of the control animals. All of the carbohydrate fed animals (P less than 0.005 vs control) had calcium bilirubinate crystals and sludge, while microscopic, black stones were present in six of these eight animals (P less than 0.05 vs control). Although hepatic bile bilirubin was unchanged in the carbohydrate-fed group, these animals had a significant increase in hepatic bile calcium (P less than 0.005) and phospholipids (P less than 0.005) when compared to controls. Carbohydrate-fed animals also had a significant increase in gallbladder bile concentrations of phospholipids (P less than 0.001), calcium (P less than 0.001), unconjugated (P less than 0.005), conjugated (P less than 0.005), and total bilirubin (P less than 0.001) as compared to controls. These data indicate that in the prairie dog, carbohydrate feeding results in increased biliary concentrations of phospholipids, calcium and bilirubin, and formation of calcium bilirubinate crystals, sludge and microscopic gallstones.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1986
550. Interaction of chenodeoxycholic acid and dietary cholesterol in the treatment of cholesterol gallstones
- Author
-
Lawrence DenBesten, Joel J. Roslyn, Stephen L. Kuchenbecker, Jeffrey E. Doty, Henry A. Pitt, and Vicki Porter-Fink
- Subjects
Male ,medicine.medical_specialty ,Cholesterol gallstones ,Chenodeoxycholic Acid ,Cholesterol, Dietary ,chemistry.chemical_compound ,Cholelithiasis ,Chenodeoxycholic acid ,Internal medicine ,medicine ,Animals ,Bile ,business.industry ,Cholesterol ,Sciuridae ,Lipid metabolism ,General Medicine ,Gallstones ,Cholesterol gallstone ,medicine.disease ,Functioning gallbladder ,Lipid Metabolism ,Endocrinology ,chemistry ,Surgery ,business ,Dietary Cholesterol - Abstract
Standard doses of chenodeoxycholic acid (15 mg/kg/day) fail to dissolve gallstones in 30 to 50 percent of patients with radiolucent gallstones in a functioning gallbladder. In humans, increasing dietary cholesterol produces increased biliary secretion of cholesterol. Restriction of dietary cholesterol reduces the minimum effective dose of chenodeoxycholic acid and speeds gallstone dissolution. In this study we investigated the interaction of dietary cholesterol and chenodeoxycholic acid in the prevention of gallstones in the prairie dog gallstone model. In animals fed a moderately lithogenic diet, standard doses of chenodeoxycholic acid failed to prevent gallstones. Reduction of the cholesterol stimulus or doubling the dose of chenodeoxycholic acid prevented the formation of gallstones. These findings support the hypothesis that the formation and dissolution of cholesterol gallstones are an expression of the relative strengths of saturating and desaturating stimuli. Therefore, rational therapy for cholesterol gallstone dissolution and prevention requires both reduction of lithogenic stimuli and optimal titration of chenodeoxycholic acid.
- Published
- 1982
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.